(UroToday.com) The ANZUP 2021 virtual annual scientific meeting included a presentation by Dr. Eli Van Allen discussing the convergence of machine learning and genomics for precision cancer medicine in genitourinary cancers and beyond. As both a medical oncologist and a clinician he utilizes computational biology to assess canceromic biology for the improvement of cancer outcomes. Dr. Van Allen notes that for the last 15-20 years, there has been expanding data at the point of care, including the cost of sequencing genomes substantially decreasing and the data points available per patient increasing. This includes: whole exomes, genomes, transcriptomes, epigenomics, histopathology and unstructured electronic health record data, as summarized in the following figure: